Target intelligence / Profile preview

ZNF747 divergent transcript (ZNF747-DT)

Target
ZNF747-DT
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ZNF747 divergent transcript (ZNF747-DT) is a primate-specific long non-coding RNA located at chromosome 16p11.2 and transcribed divergently relative to the protein-coding zinc finger gene ZNF747. Divergent transcription is a common process where RNA polymerase II initiates transcription in both directions from CpG-rich promoters, producing upstream antisense RNAs (including lncRNAs such as ZNF747-DT). Such transcripts can be involved in regulatory functions, including the modulation of gene expression and chromatin structure, but for ZNF747-DT, direct biological roles and functional significance remain inadequately characterized as of the current literature. Divergent long non-coding RNAs are frequently associated with protein-coding genes but typically lack stable or well-defined functions, especially for less-studied examples like ZNF747-DT. ZNF747-DT’s locus is precisely mapped, and its classification is reliable per referenced databases, but there is little to no evidence for disease involvement, direct drug targeting, or formal biomarker or safety concern status as of this date.

Other names
AC002310.12ZNF747-DT
02

Biological functions

Regulation of gene transcription (potential, typical for lncRNAs—direct evidence for ZNF747-DT specifically not published)May be involved in chromatin remodeling or transcriptional regulation (based on analogy to other divergent lncRNAs)
03

Disease associations

Other (No direct association to specific disease roles published as of search date)

Beyond the preview

Go deeper on ZNF747 divergent transcript (ZNF747-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF747 divergent transcript (ZNF747-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call